{"id":741516,"date":"2023-03-21T08:10:43","date_gmt":"2023-03-21T12:10:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/"},"modified":"2023-03-21T08:10:43","modified_gmt":"2023-03-21T12:10:43","slug":"humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/","title":{"rendered":"Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023"},"content":{"rendered":"
\n

DURHAM, N.C., March 21, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its financial results for the fourth quarter and year ended December 31, 2022, on Friday, March 24, 2023. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update.<\/p>\n\n\n\n\n\n\n
\n Title:<\/strong>\n <\/td>\nHumacyte Fourth Quarter and Year-End 2022 Financial Results and Corporate Update<\/td>\n<\/tr>\n
\n Date:<\/strong>\n <\/td>\nFriday, March 24, 2023<\/td>\n<\/tr>\n
\n Time:<\/strong>\n <\/td>\n8:00 AM ET<\/td>\n<\/tr>\n
\n Conference Call Details:<\/strong>\n <\/td>\nToll-Free: 1-877-704-4453
International: 1-201-389-0920
Conference ID#: 13736105<\/td>\n<\/tr>\n
\n Webcast:<\/strong>\n <\/td>\n\n Webcast Link \u2013 Click Here<\/a>\n <\/td>\n<\/tr>\n<\/table>\n

The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live broadcast and will be accessible on the investors section of the Company\u2019s website for at least 30 days.<\/p>\n

\n About Humacyte<\/strong>
\n
Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and complex tissue and organ systems designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte\u2019s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte\u2019s 6mm HAV for arteriovenous (AV) access for performing hemodialysis was the first product candidate to receive the FDA\u2019s Regenerative Medicine Advanced Therapy (RMAT) designation, and has also received FDA Fast Track designation. The HAV received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense. For more information, visit www.Humacyte.com<\/a>.<\/p>\n

\n Humacyte Investor Contact:<\/strong>
\n
Joyce Allaire
LifeSci Advisors LLC
+1-617-435-6602
jallaire@lifesciadvisors.com<\/a>
investors@humacyte.com<\/a><\/p>\n

\n Humacyte Media Contact:<\/strong>
\n
Rich Luchette
Precision Strategies
+1-202-845-3924
rich@precisionstrategies.com
media@humacyte.com<\/a>\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

DURHAM, N.C., March 21, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its financial results for the fourth quarter and year ended December 31, 2022, on Friday, March 24, 2023. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update. Title: Humacyte Fourth Quarter and Year-End 2022 Financial Results and Corporate Update Date: Friday, March 24, 2023 Time: 8:00 AM ET Conference Call Details: Toll-Free: 1-877-704-4453International: 1-201-389-0920Conference ID#: 13736105 Webcast: Webcast Link \u2013 Click Here The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will … <\/p>\n

Continue reading “Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-741516","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nHumacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"DURHAM, N.C., March 21, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its financial results for the fourth quarter and year ended December 31, 2022, on Friday, March 24, 2023. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update. Title: Humacyte Fourth Quarter and Year-End 2022 Financial Results and Corporate Update Date: Friday, March 24, 2023 Time: 8:00 AM ET Conference Call Details: Toll-Free: 1-877-704-4453International: 1-201-389-0920Conference ID#: 13736105 Webcast: Webcast Link \u2013 Click Here The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will … Continue reading "Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-21T12:10:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjAyNyM1NDcyNDI1IzIyMDk0MzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023\",\"datePublished\":\"2023-03-21T12:10:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/\"},\"wordCount\":360,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MjAyNyM1NDcyNDI1IzIyMDk0MzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/\",\"name\":\"Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MjAyNyM1NDcyNDI1IzIyMDk0MzY=\",\"datePublished\":\"2023-03-21T12:10:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MjAyNyM1NDcyNDI1IzIyMDk0MzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MjAyNyM1NDcyNDI1IzIyMDk0MzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/","og_locale":"en_US","og_type":"article","og_title":"Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023 - Market Newsdesk","og_description":"DURHAM, N.C., March 21, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, will release its financial results for the fourth quarter and year ended December 31, 2022, on Friday, March 24, 2023. Management will host a webcast and conference call at 8:00 a.m. ET to provide a corporate and financial update. Title: Humacyte Fourth Quarter and Year-End 2022 Financial Results and Corporate Update Date: Friday, March 24, 2023 Time: 8:00 AM ET Conference Call Details: Toll-Free: 1-877-704-4453International: 1-201-389-0920Conference ID#: 13736105 Webcast: Webcast Link \u2013 Click Here The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will … Continue reading \"Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-21T12:10:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjAyNyM1NDcyNDI1IzIyMDk0MzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023","datePublished":"2023-03-21T12:10:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/"},"wordCount":360,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjAyNyM1NDcyNDI1IzIyMDk0MzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/","name":"Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjAyNyM1NDcyNDI1IzIyMDk0MzY=","datePublished":"2023-03-21T12:10:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjAyNyM1NDcyNDI1IzIyMDk0MzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MjAyNyM1NDcyNDI1IzIyMDk0MzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/humacyte-to-present-fourth-quarter-and-full-year-financial-results-and-provide-corporate-update-on-march-24-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741516","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=741516"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741516\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=741516"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=741516"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=741516"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}